2015 Research Annual Report

Bone Marrow Transplant and Immune Deficiency

Algorithm enables prompt response to high-risk cases of transplant-associated thrombotic microangiopathy (TMA)

After children undergo hematopoietic cell transplantation (HSCT), one of the most severe complications they can develop is thrombotic microangiopathy (TMA). This condition can trigger a cascade of events leading to potentially fatal multi-organ injury.